Show results for
Refine by
Inflammatory Disease Equipment & Supplies In Qatar
177 equipment items found
Manufactured by:Bilix Co., Ltd. based inYongin, SOUTH KOREA
Many inflammatory diseases are associated with reactive oxygen species(ROS) in the body. The bilirubin nanoparticle has strong antioxidant, ROS scavenging, and immune modulating properties which effectively eliminate the disease-causing ...
Manufactured by:Advanced Accelerator Applications SA based inRueil-Malmaison Cedex, FRANCE
AAA brand names for FDG (most widely used PET tracer): Oncology, cardiology, neurology. Infectious and inflammatory ...
by:AbelZeta Inc. based inRockville, MARYLAND (USA)
PRODUCT: C-CAR168. INDICATION: Autoimmune. PLATFORM: CAR-T. PRECLINICAL: CD20 / BCMA. IIT: -. PHASE 1/1B: -. PHASE 2: -. PARTNERS: ...
Manufactured by:JD Bioscience Inc. (JDB) based inBuk-gu, SOUTH KOREA
IBD, including ulcerative colitis (UC) and crohn’s disease (CD) can be caused by genetic and environmental factors and can induces uncontrolled activation of intestinal immune cells. Pro-inflammatory cytokines, such as IL-6 and TNF, produced by activated immune cells are suggested to drive the perpetuation of inflammation and tissue ...
Manufactured by:Finch Therapeutics Group, Inc. based inSomerville, MASSACHUSETTS (USA)
In collaboration with Takeda Pharmaceuticals, we are developing FIN-524 and FIN-525, orally administered, Targeted Consortia product candidates designed for the treatment of ulcerative colitis (UC) and Crohn’s disease (CD), respectively. UC and CD are the two most common types of IBD, an autoimmune condition that causes inflammation of the gastrointestinal (GI) ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-CSF3R / G-CSFR is an antibody that targets G-CSF. I t can be used in the research of inflammatory diseases. MW :150 ...
by:Horizon Therapeutics plc based inSaint Kevin`s, IRELAND
Exclusive collaboration to develop novel, multi-specific fusion protein based therapies for autoimmune and inflammatory ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Fezakinumab (Anti-IL-22) is a monoclonal antibody targeting IL-22. It can be used for the research of inflammatory disease, such as psoriasis and rheumatoid arthritis. MW :145.5 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-IL-23 (LY2525623) is a human monoclonal antibody targeting Interleukin-23 (IL-23). It has the potential to be researched for autoimmune inflammatory diseases. MW: 144.26 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-CSF2Rb / CD131 (CSL311) is a monoclonal antibody that targets CSF2Rb and CD131. It is used in treatment of chronic inflammatory diseases where the human βc receptor is central to pathogenesis. MW: 145.5 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Cendakimab (anti-IL-13) is a humanized, recombinant monoclonal antibody against the interleukin-13 (IL-13) molecule with the potential to treat allergic/inflammatory diseases (e.g., asthma and eosinophilic esophagitis). MW: 146.44 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Avdoralimab (Anti-Complement C5aR1) is a fully human IgGκ monoclonal antibody targeting the complement C5a receptor 1 (C5aR1), that prevents its binding to C5a. Avdoralimab can be used for complement-driven inflammatory diseases and solid tumours research. MW: 145.5 ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Timolumab (Anti-AOC3 / VAP1) is a fully human monoclonal antibody directed against vascular adhesion protein-1 (VAP-1). Timolumab has the potential to be used in research on chronic inflammatory diseases. MW : 150 ...
Manufactured by:Reglagene Holding, Inc. based inTucson, ARIZONA (USA)
RGNXXXX is a potent, orally administered, blood-brain barrier penetrant therapy that is being optimized for the treatment of anti-infectivity and neuro-inflammation, such as acute COVID-19 and neuro-inflammatory diseases, respectfully. ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Anti-CXCR5 / CD185 (SAR113244) is a humanized monoclonal antibody that specifically targets CXCR5. It can be used in the treatment of arthritis, autoimmune diseases, inflammatory diseases, graft rejection, and cancer . MW :144.1 ...
Manufactured by:Dermagnostix GmbH based inFreiburg, GERMANY
PatternX identifies inflammatory disease markers, characterizes endotypes, and supports companion and complementary diagnostics development, as well as patient stratification and selection in clinical ...
Manufactured by:3B Scientific GmbH based inHamburg, GERMANY
This model shows the usual benign and malignant changes in the colon and rectum. These include diverticula, polyps, hemorrhoids, fistulae, fissures, chronic inflammatory diseases (Crohn’s disease and ulcerative colitis), as well as intestinal cancer in various ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
CCR6 antagonist 1 is a CCR6 antagonist that inhibits the CCL20/CCR6 axis. CCR6 antagonist 1 can be used in the research of autoimmune-mediated inflammatory diseases, such as inflammatory bowel diseases ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
CXCR3 antagonist 1 (compound 6c) is a selective and non-cytotoxic CXCR3 antagonist (IC50=0.06 µM). CXCR3 antagonist 1 has potential in researching inflammatory diseases (including inflammatory bowel disease, multiple sclerosis, rheumatoid arthritis, and ...
Manufactured by:Selleck Chemicals LLC based in, NORTH AMERICA
Eldelumab selectively binds to CXCL10 and blocks CXCL10-induced calcium flux and cell migration. Eldelumab can be used in studies of autoimmune and auto-inflammatory diseases such as rheumatoid arthritis, ulcerative colitis and crohn's disease. MW: 145.5 ...